Hayes DN, Gleysteen JP, Schwartz DL. For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting. J Clin Oncol 2022 Apr 21:JCO2200274. doi: 10.1200/JCO.22.00274.
PMID: 35446600